Notice: This company has been marked as potentially delisted and may not be actively trading. Medicis Pharmaceutical (MRX) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsCompetitorsDividendEarningsHeadlinesOptions ChainTrends MRX vs. BGC, SNEX, FRGE, TOP, GSIW, ICE, CME, NDAQ, TW, and TROWShould you be buying Medicis Pharmaceutical stock or one of its competitors? The main competitors of Medicis Pharmaceutical include BGC Group (BGC), StoneX Group (SNEX), Forge Global (FRGE), TOP Financial Group (TOP), Garden Stage (GSIW), Intercontinental Exchange (ICE), CME Group (CME), Nasdaq (NDAQ), Tradeweb Markets (TW), and T. Rowe Price Group (TROW). These companies are all part of the "security & commodity brokers, dealers, exchanges & services" industry. Medicis Pharmaceutical vs. BGC Group StoneX Group Forge Global TOP Financial Group Garden Stage Intercontinental Exchange CME Group Nasdaq Tradeweb Markets T. Rowe Price Group Medicis Pharmaceutical (NYSE:MRX) and BGC Group (NASDAQ:BGC) are both finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, community ranking, dividends, valuation, earnings, analyst recommendations, media sentiment, risk and institutional ownership. Do institutionals and insiders believe in MRX or BGC? 52.1% of BGC Group shares are owned by institutional investors. 3.8% of Medicis Pharmaceutical shares are owned by company insiders. Comparatively, 26.3% of BGC Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the MarketBeat Community favor MRX or BGC? BGC Group received 171 more outperform votes than Medicis Pharmaceutical when rated by MarketBeat users. However, 66.81% of users gave Medicis Pharmaceutical an outperform vote while only 59.74% of users gave BGC Group an outperform vote. CompanyUnderperformOutperformMedicis PharmaceuticalOutperform Votes15166.81% Underperform Votes7533.19% BGC GroupOutperform Votes32259.74% Underperform Votes21740.26% Does the media prefer MRX or BGC? In the previous week, BGC Group had 2 more articles in the media than Medicis Pharmaceutical. MarketBeat recorded 2 mentions for BGC Group and 0 mentions for Medicis Pharmaceutical. BGC Group's average media sentiment score of 0.18 beat Medicis Pharmaceutical's score of 0.00 indicating that BGC Group is being referred to more favorably in the news media. Company Overall Sentiment Medicis Pharmaceutical Neutral BGC Group Neutral Is MRX or BGC a better dividend stock? Medicis Pharmaceutical pays an annual dividend of $0.56 per share and has a dividend yield of 2.0%. BGC Group pays an annual dividend of $0.08 per share and has a dividend yield of 0.8%. BGC Group pays out 32.0% of its earnings in the form of a dividend. Do analysts rate MRX or BGC? Medicis Pharmaceutical currently has a consensus price target of $30.71, suggesting a potential upside of 8.38%. Given Medicis Pharmaceutical's stronger consensus rating and higher probable upside, analysts plainly believe Medicis Pharmaceutical is more favorable than BGC Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medicis Pharmaceutical 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00BGC Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is MRX or BGC more profitable? BGC Group has a net margin of 5.49% compared to Medicis Pharmaceutical's net margin of 0.00%. BGC Group's return on equity of 47.68% beat Medicis Pharmaceutical's return on equity.Company Net Margins Return on Equity Return on Assets Medicis PharmaceuticalN/A N/A N/A BGC Group 5.49%47.68%11.51% Which has higher earnings and valuation, MRX or BGC? Medicis Pharmaceutical has higher earnings, but lower revenue than BGC Group. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMedicis Pharmaceutical$1.24B1.60$141.30MN/AN/ABGC Group$2.15B2.36$36.26M$0.2541.60 SummaryBGC Group beats Medicis Pharmaceutical on 10 of the 17 factors compared between the two stocks. Ad Crypto 101 MediaMusk Says ‘Dollar Will Be Worth Nothing…’Coins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over $3 Million worth of crypto – and he's not the only one at the top interested in digital assets…Click here to reserve your free seat at the Crypto Community Summit Get Medicis Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for MRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MRX vs. The Competition Export to ExcelMetricMedicis PharmaceuticalSecurity & commodity brokers IndustryFinance SectorNYSE ExchangeMarket Cap$1.99B$25.08B$10.80B$19.82BDividend Yield1.97%1.39%9.89%3.50%P/E RatioN/A19.5230.7941.71Price / Sales1.606.65110.9619.74Price / CashN/A22.8530.6521.65Price / Book2.084.923.784.66Net Income$141.30M$907.78M$996.08M$983.45M Medicis Pharmaceutical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MRXMedicis Pharmaceutical0.2384 of 5 stars$28.34-2.2%$30.71+8.4%N/A$1.99B$1.24B0.002,074BGCBGC Group2.5756 of 5 stars$10.40+0.2%N/A+134.8%$5.06B$2.15B41.603,895SNEXStoneX Group3.1502 of 5 stars$97.27+1.5%N/A+47.8%$3.09B$85.38B13.484,000Upcoming EarningsShort Interest ↓Positive NewsFRGEForge Global3.5658 of 5 stars$0.84-6.7%$4.50+437.4%-70.4%$154.91M$79.26M-1.953Short Interest ↓Gap UpTOPTOP Financial Group0.6844 of 5 stars$1.61-3.6%N/A-62.9%$59.61M$8.04M0.0010GSIWGarden StageN/A$0.67-1.5%N/AN/A$10.47M$1.36M0.0013Short Interest ↓News CoverageGap DownICEIntercontinental Exchange4.9237 of 5 stars$155.55-0.6%$174.13+11.9%+40.1%$89.31B$9.90B36.8613,222Analyst UpgradeShort Interest ↓Positive NewsCMECME Group4.7194 of 5 stars$225.28+0.8%$224.47-0.4%+6.7%$81.12B$5.58B23.693,565Short Interest ↑Analyst RevisionNews CoverageNDAQNasdaq4.7903 of 5 stars$78.76+0.9%$80.87+2.7%+47.7%$45.27B$6.06B47.168,525Dividend AnnouncementAnalyst RevisionNews CoveragePositive NewsTWTradeweb Markets4.4579 of 5 stars$128.85+0.1%$132.38+2.7%+41.2%$30.44B$1.63B61.651,179Short Interest ↓TROWT. Rowe Price Group4.7596 of 5 stars$118.77-0.9%$115.55-2.7%+20.8%$26.39B$6.46B12.997,906Positive News Related Companies and Tools Related Companies BGC Competitors SNEX Competitors FRGE Competitors TOP Competitors GSIW Competitors ICE Competitors CME Competitors NDAQ Competitors TW Competitors TROW Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:MRX) was last updated on 11/16/2024 by MarketBeat.com Staff From Our PartnersThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Coins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredTech funds are hemorrhaging cash: Sell this stock nowSomething very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicis Pharmaceutical Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicis Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
